Propel Bio Management, LLC

Investment Portfolio & 13F Holdings Analysis

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
18
Total Value
86073350
Accession Number
0000898432-25-000357
Form Type
13F-HR
Manager Name
Propel-Bio-Management
Data Enrichment
78% identified
14 identified4 unidentified

Holdings

18 positions
Manager:
Search and click to pin securities to the top
PLAINS GP HOLDINGS LP
Shares:1.3M
Value:$27.2M
MADRIGAL PHARMACEUTICALS, INC.
Shares:30.0K
Value:$9.9M
Akero Therapeutics, Inc.
Shares:228.9K
Value:$9.3M
Phathom Pharmaceuticals, Inc.
Shares:1.1M
Value:$7.1M
ACHIEVE LIFE SCIENCES, INC.
Shares:2.5M
Value:$6.5M
Applied Therapeutics, Inc.
Shares:11.3M
Value:$5.5M
Avidity Biosciences, Inc.
Shares:178.5K
Value:$5.3M
ABEONA THERAPEUTICS INC.
Shares:624.0K
Value:$3.0M
TScan Therapeutics, Inc.
Shares:2.1M
Value:$2.9M
DELCATH SYSTEMS, INC.
Shares:177.6K
Value:$2.3M
Syndax Pharmaceuticals Inc
Shares:183.3K
Value:$2.3M
488445206
Shares:179.9K
Value:$1.3M
Milestone Pharmaceuticals Inc.
Shares:1.5M
Value:$1.2M
F5888J116
Shares:166.4K
Value:$1.0M
Compass Therapeutics, Inc.
Shares:228.3K
Value:$433.8K
Athira Pharma, Inc.
Shares:1.5M
Value:$425.3K
28249U204
Shares:146.4K
Value:$423.0K
169CVR016
Shares:79.4K
Value:$38.5K